Cargando…
NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication
Therapeutic administration of type I IFN (IFN-I) is a common treatment option for individuals suffering from hepatitis B virus (HBV) infection. IFN-I therapy, however, has a relatively low response rate in HBV-infected patients and can induce serious side-effects, limiting its clinical efficacy. The...
Autores principales: | Xu, Fengchao, Song, Hongxiao, An, Beiying, Xiao, Qingfei, Cheng, Genhong, Tan, Guangyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797949/ https://www.ncbi.nlm.nih.gov/pubmed/31681236 http://dx.doi.org/10.3389/fmicb.2019.02382 |
Ejemplares similares
-
Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx
por: Tan, Guangyun, et al.
Publicado: (2018) -
Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx
por: Xu, Fengchao, et al.
Publicado: (2018) -
When Hepatitis B Virus Meets Interferons
por: Tan, Guangyun, et al.
Publicado: (2018) -
TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition
por: Song, Hongxiao, et al.
Publicado: (2023) -
STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain
por: Song, Hongxiao, et al.
Publicado: (2021)